لماذا كان رؤية Bridget Ogilvie للسلامة تغير البنية التحتية العلمية

Parasitic worms like roundworms and tapeworms evade host immune systems by altering protein expression in response to antibodies—a biological mechanism Bridget Ogilvie spent her early career decoding.

Building the foundations of modern genomics

Ogilvie's transition from a PhD researcher at Cambridge to the director of the Wellcome Trust in 1991 coincided with a massive influx of capital. In 1995, the Trust acquired significant funding following the sale of its linked pharmaceutical company, providing the budget necessary to realize a vision centered on physical scientific infrastructure.

Working alongside the UK Medical Research Council, Ogilvie helped secure Hinxton Hall in Cambridgeshire to develop the Sanger Centre (now the Wellcome Sanger Institute). Under the leadership of biologist John Sulston, this center played a pivotal role in the Human Genome Project, ensuring that the resulting sequencing data remained a public good rather than being privatized.

Scaling scientific capacity globally

Beyond genomics, Ogilvie focused on the physical requirements of research. She was instrumental in persuading the UK government to match £300 million provided by the Trust to establish a joint infrastructure fund, which allowed universities to modernize buildings, purchase equipment, and develop shared facilities.

Her initiatives extended into tropical medicine, establishing research units in Africa and Southeast Asia to bolster scientific capacity in low- and middle-income countries. By prioritizing investments in both large-scale centers and individual early-career researchers, she helped create a more robust and interconnected global scientific workforce.

Ogilvie's legacy continues through the established research hubs and the enduring principle of open-access genomic data that she fought to protect.

Source: Bridget Ogilvie obituary: parasitologist who championed biomedical labs and scientific evidence
Domain: nature.com